Fischer reports, “The company, which is expected to finish 2021 with more than $80 million in revenue, is pursuing a similar strategy to several other media companies that are trying to remain independent: acquire small brands to get bigger incrementally.
“Details: PharmaVOICE is a hyper-niche publication read by roughly 60,000 pharmaceutical executives. The company, which also produces events and podcasts, will remain a standalone brand under Industry Dive.
“This is IndustryDive’s fourth deal. In June 2020 it acquired a content marketing studio from NewsCred, a global technology company, which it combined with its own content studio and relaunched as studioID.”
Read more here.
Ben Pershing, the politics editor of The Wall Street Journal, is leaving the news organization.…
New York Times executive editor Joe Kahn sent out the following on Friday: A January 2010 front…
Brent Jones, the senior vice president of training, culture and community at Dow Jones, is…
The Wall Street Journal is looking for an editor to lead its coverage of logistics…
The Wall Street Journal seeks an enterprising and ambitious reporter to cover the intersection of…
The Wall Street Journal is seeking a reporter in Washington, DC, to chronicle one of…